THMO (ThermoGenesis Holdings, Inc.) Return on Gross Profit

Corporate emblem and logo of ThermoGenesis Holdings, Inc. (THMO)

ThermoGenesis develops automated cell separation systems and biobanking software, leveraging patented centrifuge technology. The gross margin fluctuations on this GURU.Markets chart show that the 21.10 level is the current value. The business relies on deep system integration within laboratories, which creates high switching costs for equipment. Low geopolitical risks and the humanitarian status of medicine ensure stable global distribution.

thermogenesis.com (THMO) Gross Profitability: for the period 07/04/2022 - 08/04/2024

Financial and market metric breakdowns for ThermoGenesis Holdings, Inc. (THMO)

- business market valuation indicators:
Basic company analysis:THMO (ThermoGenesis Holdings Inc.)
Manufactured products of ThermoGenesis Holdings

ThermoGenesis (THMO) struggle for survival in the automated cell processing segment is directly reflected in its gross margin fluctuations. This indicator measures the portion of revenue remaining after deducting direct production costs, which determines the fundamental efficiency of the business model. Analyzing the spread between the selling price and the cost of goods sold allows investors to assess the company's ability to generate profit amid resource shortages.